MCM2 and meningioma: ANXA3 as previously described in other tumours51 and now confirmed in meningioma to control the activation of the ERK1/2 pathway (Fig. 6e), suggesting regulation of proliferation via this pathway resulting in increased DNA biosynthesis and the requirement of MCM2 protein for DNA replication (Fig. 6, Fig. 7b).